RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers
New molecule to enable RefleXion’s SCINTIX therapy to treat most solid tumors
Stay updated with breaking news from Thorsten Melcher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New molecule to enable RefleXion’s SCINTIX therapy to treat most solid tumors
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract/AllianceEckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients 13.09.2023 / 15:00 CET/CESTThe issuer is solely responsible for the content of this an...
RefleXion Medical announced today that it entered into a non-exclusive, worldwide licensing agreement with Mirada Medical.
Press release content from PR Newswire. The AP news staff was not involved in its creation.